25 XP   0   0   10

SomnoMed Ltd
Buy, Hold or Sell?

Let's analyse Somnomed together

PenkeI guess you are interested in SomnoMed Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SomnoMed Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about SomnoMed Ltd

I send you an email if I find something interesting about SomnoMed Ltd.

Quick analysis of Somnomed (30 sec.)










What can you expect buying and holding a share of Somnomed? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.21
Expected worth in 1 year
A$0.01
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.20
Return On Investment
-94.5%

For what price can you sell your share?

Current Price per Share
A$0.21
Expected price per share
A$0 - A$0.385
How sure are you?
50%

1. Valuation of Somnomed (5 min.)




Live pricePrice per Share (EOD)

A$0.21

Intrinsic Value Per Share

A$-1.93 - A$-0.23

Total Value Per Share

A$-1.72 - A$-0.02

2. Growth of Somnomed (5 min.)




Is Somnomed growing?

Current yearPrevious yearGrowGrow %
How rich?$14.4m$17.9m-$3.4m-24.0%

How much money is Somnomed making?

Current yearPrevious yearGrowGrow %
Making money-$5.1m-$2.8m-$2.3m-44.5%
Net Profit Margin-9.6%-6.1%--

How much money comes from the company's main activities?

3. Financial Health of Somnomed (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#225 / 340

Most Revenue
#110 / 340

Most Profit
#223 / 340

Most Efficient
#156 / 340

What can you expect buying and holding a share of Somnomed? (5 min.)

Welcome investor! Somnomed's management wants to use your money to grow the business. In return you get a share of Somnomed.

What can you expect buying and holding a share of Somnomed?

First you should know what it really means to hold a share of Somnomed. And how you can make/lose money.

Speculation

The Price per Share of Somnomed is A$0.21. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Somnomed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Somnomed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.21. Based on the TTM, the Book Value Change Per Share is A$-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Somnomed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.05-22.7%-0.05-22.7%-0.03-12.6%-0.04-17.7%-0.03-11.9%
Usd Book Value Change Per Share-0.03-15.3%-0.03-15.3%-0.03-12.4%-0.01-5.9%0.013.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.0314.2%0.017.1%
Usd Total Gains Per Share-0.03-15.3%-0.03-15.3%-0.03-12.4%0.028.3%0.0210.2%
Usd Price Per Share0.62-0.62-0.78-0.91-1.29-
Price to Earnings Ratio-12.96--12.96--29.61--73.96-272.93-
Price-to-Total Gains Ratio-19.26--19.26--30.07--40.92--4.00-
Price to Book Ratio4.63-4.63-4.73-5.90-8.52-
Price-to-Total Gains Ratio-19.26--19.26--30.07--40.92--4.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.135912
Number of shares7357
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share-0.03-0.01
Usd Total Gains Per Share-0.030.02
Gains per Quarter (7357 shares)-236.11128.81
Gains per Year (7357 shares)-944.45515.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-944-954879-364505
20-1889-18981758-7271020
30-2833-28422637-10911535
40-3778-37863515-14542050
50-4722-47304394-18182565
60-5667-56745273-21823080
70-6611-66186152-25453595
80-7556-75627031-29094110
90-8500-85067910-32724625
100-9445-94508789-36365140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%3.07.00.030.0%7.012.01.035.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%12.08.00.060.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%2.00.03.040.0%2.00.08.020.0%2.00.018.010.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%5.05.00.050.0%12.08.00.060.0%

Fundamentals of Somnomed

About SomnoMed Ltd

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively. In addition, it also provides sleep test at home under the Sunrise brand name. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Fundamental data was last updated by Penke on 2024-04-03 18:43:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of SomnoMed Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Somnomed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • A Net Profit Margin of -9.6% means that $-0.10 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SomnoMed Ltd:

  • The MRQ is -9.6%. The company is making a loss. -1
  • The TTM is -9.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-9.6%0.0%
TTM-9.6%YOY-6.1%-3.5%
TTM-9.6%5Y-3.9%-5.6%
5Y-3.9%10Y-3.6%-0.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-11.2%+1.6%
TTM-9.6%-19.6%+10.0%
YOY-6.1%-14.4%+8.3%
5Y-3.9%-21.3%+17.4%
10Y-3.6%-24.8%+21.2%
1.1.2. Return on Assets

Shows how efficient Somnomed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • -12.8% Return on Assets means that Somnomed generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SomnoMed Ltd:

  • The MRQ is -12.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.8%TTM-12.8%0.0%
TTM-12.8%YOY-7.6%-5.2%
TTM-12.8%5Y-4.9%-7.9%
5Y-4.9%10Y-4.7%-0.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.8%-4.0%-8.8%
TTM-12.8%-4.5%-8.3%
YOY-7.6%-4.8%-2.8%
5Y-4.9%-4.0%-0.9%
10Y-4.7%-5.2%+0.5%
1.1.3. Return on Equity

Shows how efficient Somnomed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • -35.7% Return on Equity means Somnomed generated $-0.36 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SomnoMed Ltd:

  • The MRQ is -35.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -35.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-35.7%TTM-35.7%0.0%
TTM-35.7%YOY-16.0%-19.7%
TTM-35.7%5Y-11.8%-23.9%
5Y-11.8%10Y-8.7%-3.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-35.7%-3.9%-31.8%
TTM-35.7%-5.6%-30.1%
YOY-16.0%-5.9%-10.1%
5Y-11.8%-6.1%-5.7%
10Y-8.7%-7.1%-1.6%

1.2. Operating Efficiency of SomnoMed Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Somnomed is operating .

  • Measures how much profit Somnomed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • An Operating Margin of -4.9% means the company generated $-0.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SomnoMed Ltd:

  • The MRQ is -4.9%. The company is operating very inefficient. -2
  • The TTM is -4.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-4.9%TTM-4.9%0.0%
TTM-4.9%YOY-5.7%+0.8%
TTM-4.9%5Y-2.3%-2.5%
5Y-2.3%10Y-2.3%0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.9%-21.4%+16.5%
TTM-4.9%-18.0%+13.1%
YOY-5.7%-13.7%+8.0%
5Y-2.3%-19.2%+16.9%
10Y-2.3%-24.0%+21.7%
1.2.2. Operating Ratio

Measures how efficient Somnomed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.05 means that the operating costs are $1.05 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.049. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.049. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.049TTM1.0490.000
TTM1.049YOY1.057-0.008
TTM1.0495Y1.023+0.025
5Y1.02310Y1.032-0.008
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0491.428-0.379
TTM1.0491.433-0.384
YOY1.0571.431-0.374
5Y1.0231.440-0.417
10Y1.0321.382-0.350

1.3. Liquidity of SomnoMed Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Somnomed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.50 means the company has $1.50 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.498. The company is just able to pay all its short-term debts.
  • The TTM is 1.498. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.498TTM1.4980.000
TTM1.498YOY1.275+0.223
TTM1.4985Y1.656-0.158
5Y1.65610Y2.206-0.550
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4982.787-1.289
TTM1.4982.763-1.265
YOY1.2753.488-2.213
5Y1.6563.617-1.961
10Y2.2063.537-1.331
1.3.2. Quick Ratio

Measures if Somnomed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • A Quick Ratio of 1.14 means the company can pay off $1.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.143. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.143. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.143TTM1.1430.000
TTM1.143YOY1.045+0.098
TTM1.1435Y1.414-0.271
5Y1.41410Y1.982-0.568
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1431.539-0.396
TTM1.1431.656-0.513
YOY1.0452.113-1.068
5Y1.4142.289-0.875
10Y1.9822.256-0.274

1.4. Solvency of SomnoMed Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Somnomed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Somnomed to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.64 means that Somnomed assets are financed with 64.1% credit (debt) and the remaining percentage (100% - 64.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SomnoMed Ltd:

  • The MRQ is 0.641. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.641. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.641TTM0.6410.000
TTM0.641YOY0.522+0.120
TTM0.6415Y0.506+0.136
5Y0.50610Y0.382+0.124
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6410.389+0.252
TTM0.6410.386+0.255
YOY0.5220.347+0.175
5Y0.5060.442+0.064
10Y0.3820.460-0.078
1.4.2. Debt to Equity Ratio

Measures if Somnomed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • A Debt to Equity ratio of 178.9% means that company has $1.79 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.789. The company is just able to pay all its debts with equity.
  • The TTM is 1.789. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.789TTM1.7890.000
TTM1.789YOY1.091+0.699
TTM1.7895Y1.080+0.709
5Y1.08010Y0.714+0.366
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7890.559+1.230
TTM1.7890.560+1.229
YOY1.0910.478+0.613
5Y1.0800.624+0.456
10Y0.7140.674+0.040

2. Market Valuation of SomnoMed Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Somnomed generates.

  • Above 15 is considered overpriced but always compare Somnomed to the Medical Devices industry mean.
  • A PE ratio of -12.96 means the investor is paying $-12.96 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SomnoMed Ltd:

  • The EOD is -2.851. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.965. Based on the earnings, the company is expensive. -2
  • The TTM is -12.965. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.851MRQ-12.965+10.114
MRQ-12.965TTM-12.9650.000
TTM-12.965YOY-29.614+16.649
TTM-12.9655Y-73.963+60.999
5Y-73.96310Y272.930-346.894
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.851-1.067-1.784
MRQ-12.965-1.578-11.387
TTM-12.965-2.341-10.624
YOY-29.614-2.969-26.645
5Y-73.963-2.081-71.882
10Y272.930-1.463+274.393
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SomnoMed Ltd:

  • The EOD is -2.215. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.073. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.073. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.215MRQ-10.073+7.858
MRQ-10.073TTM-10.0730.000
TTM-10.073YOY-18.959+8.885
TTM-10.0735Y-34.617+24.544
5Y-34.61710Y340.797-375.414
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.215-1.015-1.200
MRQ-10.073-1.544-8.529
TTM-10.073-2.914-7.159
YOY-18.959-6.192-12.767
5Y-34.617-4.771-29.846
10Y340.797-5.214+346.011
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Somnomed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 4.63 means the investor is paying $4.63 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of SomnoMed Ltd:

  • The EOD is 1.018. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.629. Based on the equity, the company is fair priced.
  • The TTM is 4.629. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.018MRQ4.629-3.611
MRQ4.629TTM4.6290.000
TTM4.629YOY4.728-0.099
TTM4.6295Y5.901-1.273
5Y5.90110Y8.522-2.620
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.0182.021-1.003
MRQ4.6292.379+2.250
TTM4.6292.465+2.164
YOY4.7283.219+1.509
5Y5.9013.798+2.103
10Y8.5224.163+4.359
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of SomnoMed Ltd.

3.1. Funds holding SomnoMed Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-01-31Fidelity International Small Cap Fund4.71-3898596--
2021-01-31DFA Asia Pacific Small Company Series0.029999999-25160--
Total 4.7399999990392375600.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of SomnoMed Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.050-0.0500%-0.040-19%-0.019-62%0.010-597%
Book Value Per Share--0.2060.2060%0.256-19%0.247-16%0.244-15%
Current Ratio--1.4981.4980%1.275+17%1.656-10%2.206-32%
Debt To Asset Ratio--0.6410.6410%0.522+23%0.506+27%0.382+68%
Debt To Equity Ratio--1.7891.7890%1.091+64%1.080+66%0.714+151%
Dividend Per Share----0%-0%0.046-100%0.023-100%
Eps---0.074-0.0740%-0.041-45%-0.057-22%-0.039-48%
Free Cash Flow Per Share---0.095-0.0950%-0.064-33%-0.044-54%-0.040-58%
Free Cash Flow To Equity Per Share---0.034-0.0340%-0.045+31%-0.001-96%0.009-470%
Gross Profit Margin--4.0624.0620%5.449-25%83.875-95%32.387-87%
Intrinsic Value_10Y_max---0.230--------
Intrinsic Value_10Y_min---1.930--------
Intrinsic Value_1Y_max---0.036--------
Intrinsic Value_1Y_min---0.093--------
Intrinsic Value_3Y_max---0.099--------
Intrinsic Value_3Y_min---0.367--------
Intrinsic Value_5Y_max---0.150--------
Intrinsic Value_5Y_min---0.737--------
Market Cap22804110.000-355%103704405.000103704405.0000%131395110.000-21%152570355.000-32%216599952.240-52%
Net Profit Margin---0.096-0.0960%-0.061-36%-0.039-59%-0.036-62%
Operating Margin---0.049-0.0490%-0.057+17%-0.023-52%-0.023-53%
Operating Ratio--1.0491.0490%1.057-1%1.023+2%1.032+2%
Pb Ratio1.018-355%4.6294.6290%4.728-2%5.901-22%8.522-46%
Pe Ratio-2.851+78%-12.965-12.9650%-29.614+128%-73.963+471%272.930-105%
Price Per Share0.210-355%0.9550.9550%1.210-21%1.405-32%1.995-52%
Price To Free Cash Flow Ratio-2.215+78%-10.073-10.0730%-18.959+88%-34.617+244%340.797-103%
Price To Total Gains Ratio-4.235+78%-19.259-19.2590%-30.067+56%-40.920+112%-4.000-79%
Quick Ratio--1.1431.1430%1.045+9%1.414-19%1.982-42%
Return On Assets---0.128-0.1280%-0.076-40%-0.049-62%-0.047-63%
Return On Equity---0.357-0.3570%-0.160-55%-0.118-67%-0.087-76%
Total Gains Per Share---0.050-0.0500%-0.040-19%0.027-283%0.033-250%
Usd Book Value--14499463.65314499463.6530%17984545.692-19%17345596.845-16%17118104.233-15%
Usd Book Value Change Per Share---0.032-0.0320%-0.026-19%-0.012-62%0.006-597%
Usd Book Value Per Share--0.1340.1340%0.166-19%0.160-16%0.158-15%
Usd Dividend Per Share----0%-0%0.030-100%0.015-100%
Usd Eps---0.048-0.0480%-0.026-45%-0.037-22%-0.025-48%
Usd Free Cash Flow---6662785.499-6662785.4990%-4485512.150-33%-3088123.343-54%-2813129.681-58%
Usd Free Cash Flow Per Share---0.061-0.0610%-0.041-33%-0.028-54%-0.026-58%
Usd Free Cash Flow To Equity Per Share---0.022-0.0220%-0.029+31%-0.001-96%0.006-470%
Usd Market Cap14758819.992-355%67117490.91667117490.9160%85038915.192-21%98743533.756-32%140183489.090-52%
Usd Price Per Share0.136-355%0.6180.6180%0.783-21%0.909-32%1.291-52%
Usd Profit---5176981.277-5176981.2770%-2871605.042-45%-1914022.679-63%-1655685.679-68%
Usd Revenue--54116381.34154116381.3410%46974036.822+15%43374210.753+25%35754251.338+51%
Usd Total Gains Per Share---0.032-0.0320%-0.026-19%0.018-283%0.021-250%
 EOD+3 -5MRQTTM+0 -0YOY+10 -245Y+4 -3210Y+5 -31

4.2. Fundamental Score

Let's check the fundamental score of SomnoMed Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.851
Price to Book Ratio (EOD)Between0-11.018
Net Profit Margin (MRQ)Greater than0-0.096
Operating Margin (MRQ)Greater than0-0.049
Quick Ratio (MRQ)Greater than11.143
Current Ratio (MRQ)Greater than11.498
Debt to Asset Ratio (MRQ)Less than10.641
Debt to Equity Ratio (MRQ)Less than11.789
Return on Equity (MRQ)Greater than0.15-0.357
Return on Assets (MRQ)Greater than0.05-0.128
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of SomnoMed Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.060
Ma 20Greater thanMa 500.320
Ma 50Greater thanMa 1000.386
Ma 100Greater thanMa 2000.422
OpenGreater thanClose0.235
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Net Debt  -4,102-10,543-14,6442,442-12,2028,568-3,63415,18811,554



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets62,491
Total Liabilities40,088
Total Stockholder Equity22,403
 As reported
Total Liabilities 40,088
Total Stockholder Equity+ 22,403
Total Assets = 62,491

Assets

Total Assets62,491
Total Current Assets27,496
Long-term Assets34,996
Total Current Assets
Cash And Cash Equivalents 11,956
Net Receivables 9,029
Inventory 4,100
Other Current Assets 2,410
Total Current Assets  (as reported)27,496
Total Current Assets  (calculated)27,496
+/-0
Long-term Assets
Property Plant Equipment 12,730
Goodwill 6,491
Intangible Assets 18,974
Long-term Assets Other -6,491
Long-term Assets  (as reported)34,996
Long-term Assets  (calculated)31,704
+/- 3,292

Liabilities & Shareholders' Equity

Total Current Liabilities18,360
Long-term Liabilities21,728
Total Stockholder Equity22,403
Total Current Liabilities
Short-term Debt 2,569
Short Long Term Debt 313
Accounts payable 11,996
Other Current Liabilities 3,561
Total Current Liabilities  (as reported)18,360
Total Current Liabilities  (calculated)18,439
+/- 80
Long-term Liabilities
Long term Debt Total 20,941
Capital Lease Obligations Min Short Term Debt4,272
Other Liabilities 787
Long-term Liabilities  (as reported)21,728
Long-term Liabilities  (calculated)26,001
+/- 4,272
Total Stockholder Equity
Common Stock74,271
Retained Earnings -62,295
Accumulated Other Comprehensive Income 10,427
Total Stockholder Equity (as reported)22,403
Total Stockholder Equity (calculated)22,403
+/-0
Other
Capital Stock74,271
Cash And Equivalents11,956
Cash and Short Term Investments 11,956
Common Stock Shares Outstanding 82,149
Current Deferred Revenue233
Liabilities and Stockholders Equity 62,491
Net Debt 11,554
Net Invested Capital 39,073
Net Tangible Assets 13,098
Net Working Capital 9,136
Property Plant and Equipment Gross 23,935
Short Long Term Debt Total 23,511



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-30
> Total Assets 
118
625
7,918
4,069
4,699
7,004
6,038
7,834
8,732
12,312
16,111
19,143
27,751
40,427
41,212
45,698
34,751
61,693
56,166
58,094
62,491
62,49158,09456,16661,69334,75145,69841,21240,42727,75119,14316,11112,3128,7327,8346,0387,0044,6994,0697,918625118
   > Total Current Assets 
0
78
6,768
2,645
3,594
6,212
5,519
6,074
6,328
7,779
9,459
9,405
16,778
27,170
26,355
28,968
20,158
40,235
34,127
30,315
27,496
27,49630,31534,12740,23520,15828,96826,35527,17016,7789,4059,4597,7796,3286,0745,5196,2123,5942,6456,768780
       Cash And Cash Equivalents 
107
51
6,636
2,310
3,205
5,433
4,009
4,294
3,949
3,538
4,221
2,945
8,306
17,632
14,210
13,383
7,697
30,174
21,110
15,644
11,956
11,95615,64421,11030,1747,69713,38314,21017,6328,3062,9454,2213,5383,9494,2944,0095,4333,2052,3106,63651107
       Short-term Investments 
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000011
       Net Receivables 
0
27
132
317
381
746
1,245
1,584
2,202
3,741
4,383
5,495
7,180
7,847
10,197
13,582
10,558
6,126
8,225
9,202
9,029
9,0299,2028,2256,12610,55813,58210,1977,8477,1805,4954,3833,7412,2021,5841,245746381317132270
       Other Current Assets 
0
0
0
0
0
0
182
54
0
21
0
0
0
0
0
0
210
1,692
2,462
2,380
2,410
2,4102,3802,4621,69221000000021054182000000
   > Long-term Assets 
0
546
1,150
1,424
1,105
793
519
1,759
2,404
4,532
6,652
9,738
10,972
13,257
14,857
16,730
14,593
21,458
22,040
27,778
34,996
34,99627,77822,04021,45814,59316,73014,85713,25710,9729,7386,6524,5322,4041,7595197931,1051,4241,1505460
       Property Plant Equipment 
0
27
658
985
718
457
235
642
1,289
1,069
1,155
1,251
2,105
3,573
4,491
6,610
3,248
10,239
10,342
9,116
12,730
12,7309,11610,34210,2393,2486,6104,4913,5732,1051,2511,1551,0691,289642235457718985658270
       Goodwill 
0
0
0
0
0
0
0
0
0
1,321
2,665
5,690
5,477
6,238
6,171
6,375
6,407
6,469
6,260
6,038
6,491
6,4916,0386,2606,4696,4076,3756,1716,2385,4775,6902,6651,321000000000
       Intangible Assets 
0
520
491
440
388
336
284
232
180
487
453
402
405
384
462
485
1,367
7,929
8,581
15,448
18,974
18,97415,4488,5817,9291,3674854623844054024534871802322843363884404915200
       Other Assets 
0
0
0
0
0
0
0
857
999
1,855
2,533
2,707
2,987
3,062
3,785
3,297
3,681
3,589
4,370
9,835
3,252
3,2529,8354,3703,5893,6813,2973,7853,0622,9872,7072,5331,8559998570000000
> Total Liabilities 
3
785
716
835
786
996
1,705
2,183
2,515
3,392
4,538
6,573
6,243
7,739
10,257
12,929
16,931
27,858
24,008
30,305
40,088
40,08830,30524,00827,85816,93112,92910,2577,7396,2436,5734,5383,3922,5152,1831,7059967868357167853
   > Total Current Liabilities 
3
785
461
741
786
996
1,705
2,181
2,509
3,380
4,399
4,736
5,471
7,577
10,002
11,540
16,046
18,780
16,197
23,775
18,360
18,36023,77516,19718,78016,04611,54010,0027,5775,4714,7364,3993,3802,5092,1811,7059967867414617853
       Short-term Debt 
0
0
157
157
92
0
0
5
0
0
0
0
0
0
123
398
3,236
7,284
1,956
6,657
2,569
2,5696,6571,9567,2843,2363981230000005009215715700
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
123
1,435
3,008
4,953
0
4,877
313
3134,87704,9533,0081,43512300000000000000
       Accounts payable 
0
0
251
446
614
835
1,259
1,697
1,657
2,503
3,077
3,046
3,708
6,065
7,545
8,084
8,105
8,277
10,334
12,593
11,996
11,99612,59310,3348,2778,1058,0847,5456,0653,7083,0463,0772,5031,6571,6971,25983561444625100
       Other Current Liabilities 
3
357
54
138
80
161
249
304
307
338
1,322
1,690
1,763
1,512
2,335
3,058
4,705
2,928
3,647
4,263
3,561
3,5614,2633,6472,9284,7053,0582,3351,5121,7631,6901,32233830730424916180138543573
   > Long-term Liabilities 
0
0
255
94
0
0
0
2
5
12
139
1,837
772
161
255
1,389
885
9,077
7,811
6,530
21,728
21,7286,5307,8119,0778851,3892551617721,83713912520009425500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53
1,037
359
8,246
6,952
5,353
20,941
20,9415,3536,9528,2463591,0375300000000000000
       Other Liabilities 
0
0
0
0
0
0
0
2
5
12
139
1,837
772
161
255
352
526
831
859
1,177
787
7871,1778598315263522551617721,83713912520000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
312
248
116
52
37
110
299
1,254
6,620
9,668
9,6686,6201,254299110375211624831200000000000
> Total Stockholder Equity
115
-160
7,201
3,234
3,913
6,009
4,333
5,651
6,217
8,725
10,961
12,338
21,340
33,128
32,214
36,119
17,820
33,835
32,158
27,788
22,403
22,40327,78832,15833,83517,82036,11932,21433,12821,34012,33810,9618,7256,2175,6514,3336,0093,9133,2347,201-160115
   Retained Earnings -62,295-54,296-49,859-48,666-47,547-27,759-19,140-15,796-15,932-16,530-17,537-18,126-18,651-19,390-20,177-18,358-15,627-12,352-7,709-4,4420
   Accumulated Other Comprehensive Income 
0
-1
-35
676
967
1,096
1,239
1,334
827
1,150
2,432
2,403
3,566
4,372
4,416
6,135
7,685
8,558
7,760
7,813
10,427
10,4277,8137,7608,5587,6856,1354,4164,3723,5662,4032,4321,1508271,3341,2391,096967676-35-10
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.